4//SEC Filing
Singh Yash 4
Accession 0001209191-19-055318
CIK 0001123494other
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 6:03 PM ET
Size
7.9 KB
Accession
0001209191-19-055318
Insider Transaction Report
Form 4
Singh Yash
Executive Vice President
Transactions
- Award
Common Stock
2019-10-31+39,286→ 39,286 total - Award
Stock option (right to buy)
2019-10-31+86,614→ 86,614 totalExercise: $2.80From: 2020-10-31Exp: 2029-10-31→ Common Stock, par value $0.01 per share (86,614 underlying)
Footnotes (3)
- [F1]Represents a deferred stock award of 39,286 restricted stock units with performance based vesting conditions. These restricted stock units shall vest in equal installments on October 31, 2020, 2021 and 2022, and are linked to the achievement of a relative total shareholder return of the Issuer's common stock from October 31, 2019 to the earlier of (i) October 31, 2020 or (ii) upon a change of control (measured relative to the NASDAQ Biotechnology index and based on the 20-day trading average price before each such date, or with respect to a change of control, the per share purchase price in the change of control). The target number of these restricted stock units that may be earned is reported above; the maximum amount is 150% of the number reported.
- [F2]Includes the award described in footnote (1) above.
- [F3]The options vest in four equal installments on October 31, 2020, 2021, 2022 and 2023.
Documents
Issuer
HARVARD BIOSCIENCE INC
CIK 0001123494
Entity typeother
Related Parties
1- filerCIK 0001793157
Filing Metadata
- Form type
- 4
- Filed
- Nov 4, 7:00 PM ET
- Accepted
- Nov 5, 6:03 PM ET
- Size
- 7.9 KB